Non-Alcoholic Steatohepatitis (NASH) Market Forecast to 2028

1
Non-Alcoholic Steatohepatitis (NASH) Market
Global Analysis and Forecast to 2028

• Published Date  Apr 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Non-Alcoholic Steatohepatitis (NASH) Market
  Forecast to 2028 - COVID-19 Impact and Global
  Analysis By Product (Vitamin E and Pioglitazone,
  Ocaliva, Elafibranor, Selonsertib Cenicriviroc,
  and Others), Application (Treatment and
  Diagnosis), and Sales Channel (Hospital Pharmacy,
  Online Provider, and Retail Pharmacy)

3
Non-Alcoholic Steatohepatitis (NASH) Market
Overview
Email sales_at_theinsightpartners.com

• The non-alcoholic steatohepatitis (NASH) market
  is projected to reach US 24,266.81 million by
  2028 from US 1,631.92 million in 2021 it is
  expected to register a CAGR of 47.1 from 2021 to
  2028.
• NASH had the strongest association with COVID-19
  of all comorbid metabolic conditions, including
  hypertension and obesity. Liver injury in the
  form of increased transaminases and
  hyperbilirubinemia among COVID-19 patients can be
  attributed to a couple of factors, including
  pre-existing liver disease. The comorbidity of
  nonalcoholic fatty liver disease (NAFLD) and NASH
  in these patients makes them prone to severe
  forms of liver injury. The presence of fibrosis
  rather than NASH/NAFLD is associated with worse
  clinical outcomes and higher mortality in
  COVID-19 patients.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment -
• By Product (Vitamin E and Pioglitazone, Ocaliva,
  Elafibranor, Selonsertib Cenicriviroc, and
  Others)
• Application (Treatment and Diagnosis)
• Sales Channel (Hospital Pharmacy, Online
  Provider, and Retail Pharmacy)

Download Sample Here
5
Non-Alcoholic Steatohepatitis (NASH) Market Value
Email sales_at_theinsightpartners.com

• CAGR of 47.1
• (2021 to 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Genfit SA
• One Way Liver, S.L.
• BioPredictive S.A.S
• Cadila Pharmaceuticals Ltd.
• Prometheus Laboratories
• Siemens Healthineers AG
• Intercept Pharmaceuticals, Inc.
• Novartis AG
• Galmed Pharmaceuticals
• Laboratory Corporation of America Holdings

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com

Access Full Article Report